View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Gastroenterology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 27, 2024
2 min read
Save

GI illness outbreak, deaths linked to consumption of undercooked morel mushrooms

GI illness outbreak, deaths linked to consumption of undercooked morel mushrooms

Consumption of uncooked or undercooked morel mushrooms was “strongly associated” with a gastrointestinal illness outbreak in spring 2023 that resulted in two deaths, highlighting the importance of proper food preparation procedures.

SPONSORED CONTENT
March 26, 2024
2 min read
Save

Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes

Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes

Efruxifermin with a glucagon-like peptide-1 receptor agonist was well-tolerated and reduced hepatic fat fraction and noninvasive markers of fibrosis among patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
March 26, 2024
4 min read
Save

BLOG: Equity: Buyback rights, forfeiture and vesting

BLOG: Equity: Buyback rights, forfeiture and vesting

In our last post, we saw how rollover equity fits into the overall consideration paid to a selling physician owner of a physician practice.

SPONSORED CONTENT
March 26, 2024
2 min read
Save

GLP-1RAs associated with increased residual gastric content, despite preprocedural fasting

GLP-1RAs associated with increased residual gastric content, despite preprocedural fasting

Once-weekly glucagon-like peptide-1 receptor agonist use was associated with a “significantly higher prevalence” of increased residual gastric content among fasted patients undergoing elective procedures under anesthesia, research showed.

SPONSORED CONTENT
March 25, 2024
2 min read
Save

‘Additional preventive’ benefit of colonoscopy for CRC falls short of sigmoidoscopy

‘Additional preventive’ benefit of colonoscopy for CRC falls short of sigmoidoscopy

Colonoscopy screening reduced the incidence of colorectal cancer and related mortality by 30% and 32%, respectively, compared with usual care, although the benefit was less than that of sigmoidoscopy where no screening exists, data showed.

SPONSORED CONTENT
March 25, 2024
14 min read
Save

Source of surging autoimmunity may lie in ‘a thousand cuts’

Source of surging autoimmunity may lie in ‘a thousand cuts’

The common consensus for some time has been that the prevalence of autoimmunity and autoimmune diseases has been on the rise.

SPONSORED CONTENT
March 25, 2024
2 min read
Save

Annual deaths from excessive alcohol use increased by nearly 30% from 2016 to 2021

Annual deaths from excessive alcohol use increased by nearly 30% from 2016 to 2021

The average number of deaths from excessive alcohol use increased by 29.3% from 2016 to 2021, with an age-standardized rise in death rate from 38.1 to 47.6 per 100,000 population, according to data in Morbidity and Mortality Weekly Report.

SPONSORED CONTENT
March 25, 2024
3 min read
Save

Excess weight may be key driver of early-onset colorectal cancer

Excess weight may be key driver of early-onset colorectal cancer

Excess body weight may be a key risk factor for the development of early-onset colorectal cancer, according to research published in International Journal of Cancer.

SPONSORED CONTENT
March 22, 2024
6 min read
Save

Push to #PrioritizeCRC: Advocacy group rallies to expand colorectal cancer screening

Push to #PrioritizeCRC: Advocacy group rallies to expand colorectal cancer screening

Every March, Colorectal Cancer Awareness Month is celebrated to raise awareness of the second leading cause of cancer death in the U.S. This year, the Fight CRC advocacy group is pushing Congress to prioritize cancer screening policies.

SPONSORED CONTENT
March 21, 2024
1 min read
Save

Immunotherapy combination improves survival in advanced liver cancer

Immunotherapy combination improves survival in advanced liver cancer

The addition of nivolumab to ipilimumab significantly improved OS among adults with previously untreated advanced hepatocellular carcinoma, according to a release by the agent’s manufacturer.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails